Gastric cancer : characterization of early disease, predisposing and modulating factors
Year: 2021
Type: dissertation
Study design: Observational Study
Abstract: Gastric cancer (GC) is the fifth most common cancer worldwide and third most common cause of cancer-related deaths. In low-risk countries, such as Finland, most GCs are diagnosed at an advanced stage, which decreases the prognosis. This thesis consists of four studies. In two studies, the aim was to evaluate GC risk in elderly male smokers with atrophic corpus gastritis. The prognostic staging systems Operative Link for Gastritis Assessment (OLGA) and Operative Link on Gastric Intestinal Metaplasia Assessment (OLGIM) were assessed in these patients. We also created a new staging system, Topography, Atrophy, and Intestinal Metaplasia (TAIM), which combines atrophy and IM into one staging. In the third study the aim was to investigate the results of surgical treatment in patients with early gastric cancer (EGC) and to elucidate the extent of lymphadenectomy (D1 vs D2) on morbidity and survival. The aim of the fourth study was to investigate the cyclooxygenase (COX) profile of GC cell lines and the effect of two probiotic bacteria, Lactobacillus acidophilus and Bifidobacterium lactis, on COX expression profile. The patient materials of studies I-II were based on the previous Helsinki Gastritis Study, where 22 346 male smokers were screened for serum pepsinogen I (PGI). 1344 men with low PGI participated. The third study consisted of 94 patients with EGC operated at Helsinki University Hospital between the years 1983 and 2007. The fourth study was performed on primary and metastatic GC cell lines. COX expression profiles were determined by real-time PCR. In study I, 35 (2.6%) men were diagnosed with GC during the follow-up with incidence rate 1.94/1000 patient-years. The standardized incidence rates (SIRs) were calculated for male smokers with low and normal PGI and results were compared to an age-matched general male population (SIR 1.00). Male smokers with normal PGI had SIR 1.13; those with low PGI had SIR 2.43. In study II, OLGIM and TAIM stagings showed prognostic value in evaluating GC risk in men with atrophic corpus gastritis. In the EGC study, the extent of lymphadenectomy did not affect survival, but the risk of complications was higher in D2 operated patients and those with total gastrectomy or pancreatic resection. In the COX study, probiotic bacteria L. acidophilus and B. lactis did not affect COX-2 expression profile. Instead, L. acidophilus upregulated cytoprotective COX-1. Male smokers with atrophic corpus gastritis had an over 2-fold increased GC risk than the general male population. The staging methods OLGIM and TAIM can stratify patients with highest GC risk. Extent of lymphadenectomy did not influence on survival of the patients with EGC. Probiotic bacterium L. acidophilus may possess cytoprotective properties in the gastric mucosa.
Author: Anna A. Nieminen
Institution: University of Helsinki
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3127230063
